Overview
Treating Disrupted Sleep in Individuals With Inflammatory Bowel Disease
Status:
Completed
Completed
Trial end date:
2016-06-30
2016-06-30
Target enrollment:
0
0
Participant gender:
All
All
Summary
The purpose of this study is to determine if either a targeted type of talk therapy (Phase I) or medication, Wellbutrin, (Phase II) improve sleep disturbance and/or fatigue in individuals with Inflammatory Bowel Disease (IBD).Phase:
Phase 4Accepts Healthy Volunteers?
Accepts Healthy VolunteersDetails
Lead Sponsor:
Eva Szigethy
University of PittsburghCollaborator:
Crohn's and Colitis FoundationTreatments:
Bupropion
Criteria
Inclusion Criteria:- IBD Group:
- Biopsy confirmed Crohn's Disease
- Qualifying scores on Multidimensional Fatigue Inventory and Pittsburgh Sleep
Quality Index
- Healthy Volunteer Group:
- Does not meet any exclusion criteria
Exclusion Criteria:
- IBD Group:
- Meeting criteria for active alcohol or substance abuse or dependence
- Current ongoing treatment with Wellbutrin
- Females who are pregnant or plan to become pregnant within three months
- Sleep disorder such as apnea, restless leg syndrome or use of Continuous positive
airway pressure therapy (C-PAP)/Bilevel positive airway pressure (Bi-PAP)
- Current IBD flare requiring hospitalization with intravenous steroid treatment
- Other acute medical conditions or a history of chronic inflammatory condition
other than IBD
- Hemoglobin <10 with age and gender adjustments
- History of seizure disorder
- Acute infection within seven days
- Healthy Volunteer Group:
- History or current episode of psychiatric disorder by Diagnositic and Statistical
Manual (DSM-IV)
- Current ongoing treatment with psychoactive medications
- Medications for sleep in previous two weeks
- Females who are pregnant or plan to become pregnant within three months
- History of IBD, epilepsy, rheumatoid arthritis, lupus
- Sleep disorder such as apnea, restless leg syndrome or use of Continuous positive
airway pressure therapy (C-PAP)/Bilevel positive airway pressure (Bi-PAP)